SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $473,829 | -12.2% | 20,508 | -0.4% | 0.00% | 0.0% |
Q2 2023 | $539,793 | +3.0% | 20,582 | +1.1% | 0.00% | 0.0% |
Q1 2023 | $523,982 | -34.8% | 20,356 | -33.6% | 0.00% | 0.0% |
Q4 2022 | $804,114 | +38.6% | 30,643 | +50.5% | 0.00% | -33.3% |
Q3 2022 | $580,000 | -9.1% | 20,356 | -21.4% | 0.00% | 0.0% |
Q2 2022 | $638,000 | +150.2% | 25,882 | +471.9% | 0.00% | +200.0% |
Q1 2022 | $255,000 | +8.1% | 4,526 | +19.0% | 0.00% | 0.0% |
Q4 2021 | $236,000 | +3.5% | 3,803 | +5.8% | 0.00% | 0.0% |
Q3 2021 | $228,000 | -23.0% | 3,596 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $296,000 | +12.1% | 3,596 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $264,000 | -45.1% | 3,596 | -45.8% | 0.00% | -50.0% |
Q4 2020 | $481,000 | +52.7% | 6,630 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $315,000 | +45.8% | 6,613 | +28.4% | 0.00% | +100.0% |
Q2 2020 | $216,000 | – | 5,149 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |